Public Company News
Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals
TAIPEI, June 9, 2025 /PRNewswire/ -- Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, andTaiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW), today announced a licensing agreement, whereby Harrow has acquired the exclusive U.S. commercial rights for BYQLOVI™ ...
2025-06-09 19:00
2175
51Talk Online Education Group Announces First Quarter 2025 Results
SINGAPORE, June 9, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced its unaudited results for the first quarter endedMarch 31, 2025. First Quarter 2025 Finan...
2025-06-09 18:00
3762
Acer Reports May Revenues at NT$19.17 Billion, Up 3.1% Month-on-month
TAIPEI, June 9, 2025 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its consolidated revenues for May atNT$19.17 billion with 3.1% growth month-on-month. Consolidated revenues for year-to-May reachedNT$99.18 billion with 1.4% growth YoY, while Chromebook revenues grew 24.4%. Acer's strategy ...
2025-06-09 17:29
4050
Ascletis Announces Poster Presentations on the Study Results of ASC30 and ASC47 at the 85th Scientific Sessions of American Diabetes Association (ADA)
HONG KONG, June 8, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of its oral small moleculeGLP-1 Receptor (GLP-1R) agonist ASC30 and adipose-targeted, muscle-preserving weight loss drug candidate ASC47 will be present...
2025-06-09 08:15
2009
NAVER Expands Startup Investments in Silicon Valley with the Planned Establishment of NAVER Ventures
- Key executives, including Founder Lee Hae-jin and CEO Choi Soo-yeon, engage in discussions with the local startup ecosystem - The new investment initiative will focus on investing in promising startups inNorth America, starting with video AI startup 'TwelveLabs' - NAVER has a strong track record...
2025-06-08 08:00
3088
MicroAlgo Inc. Adopts Quantum Phase Estimation (QPE) Method to Enhance Quantum Neural Network Training
SHENZHEN, China, June 6, 2025 /PRNewswire/ -- MicroAlgo Inc. (the "Company" or "MicroAlgo") (NASDAQ: MLGO), explored the possibilities of quantum technology in various application scenarios, particularly in the training of Quantum Neural Networks (QNNs). Quantum Neural Networks combine the advant...
2025-06-06 22:20
3033
CLPS Incorporation Unveils Transformative AI Solutions: A Catalyst for Business Value Creation and Market Expansion
HONG KONG, June 6, 2025 /PRNewswire/ -- CLPS Incorporation (the "Company" or "CLPS") (Nasdaq: CLPS), today announced that itsSingapore subsidiary, CLPS Technology (Singapore) Pte. Ltd., has achieved pivotal advancements in artificial intelligence (AI) technology development and real-world scenari...
2025-06-06 20:30
2967
SUNCAR TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
NEW YORK, June 6, 2025 /PRNewswire/ -- SunCar Technology Group Inc. (the "Company" or "SunCar") (NASDAQ: SDA), an innovative leader in cloud-based, software-focused B2B auto eInsurance and auto services inChina, today announced that members of the Company will be participating at the following up...
2025-06-06 20:00
4955
Uxin to Report First Quarter 2025 Financial Results on June 12, 2025
BEIJING, June 6, 2025 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN),China's leading used car retailer, today announced that it will release its financial results for the first quarter 2025 endedMarch 31, 2025, before the U.S. market opens on June 12, 2025. Uxin's manageme...
2025-06-06 19:50
2254
DISCO topline results: 64Cu-SARTATE is highly effective in detecting tumours in NET patients compared to SOC imaging. Phase III planning underway.
HIGHLIGHTS * Topline data from Clarity's diagnostic Phase II trial, DISCO, confirms that 64Cu-SARTATE is safe and highly effective compared to standard-of-care (SOC) imaging at detecting lesions in patients with neuroendocrine tumours (NETs). * DISCO compared the diagnostic performance of 64C...
2025-06-05 21:01
2557
SK chemicals Partners with Ministry of the Interior and Safety and Local Governments to Create a Leading Waste Banner Recycling Model
"Establishing a Complete Circular System for Waste Banners Through Public-Private Collaboration" * Signing of MOU on Waste Banner Recycling for Regional and Corporate Co-Prosperity * Led by the Ministry of the Interior and Safety, with Participation from Five Local Governments: Sejong, Gangn...
2025-06-05 21:00
2355
Visionary Holdings Officially Establishes Visionary Health Technology Group Limited to Accelerate Layout in HealthTech and Greater Health Industry
TORONTO, June 5, 2025 /PRNewswire/ -- On May 21, 2025, Visionary Health Technology Group Limited, a holding subsidiary of Visionary Holdings (Nasdaq: GV), was officially established inHong Kong. This move marks a significant step in Visionary Holdings' strategic deployment in the fields of Health...
2025-06-05 21:00
4222
Turning the page on packaging waste: Amcor's AmFiber™ Performance Paper proves recyclability in Brazil
Successful trials show AmFiberTM Performance Paper can be a smart choice in Brazil's mixed-paper recycling streams ZURICH, June 5, 2025 /PRNewswire/ -- Amcor (NYSE: AMCR, ASX: AMC), a global leader in developing and producing responsible packaging solutions, announced that its AmFiber™ Performan...
2025-06-05 20:00
4165
Autohome Inc. to Hold Annual General Meeting on June 27, 2025
BEIJING, June 5, 2025 /PRNewswire/ -- Autohome Inc. (NYSE: ATHM; HKEX: 2518) ("Autohome" or the "Company"), the leading online destination for automobile consumers inChina, today announced that it will hold its annual general meeting of shareholders (the "AGM") at 18th Floor, Tower B, CEC Plaza, ...
2025-06-05 17:30
4051
Yiren Digital to Report First Quarter 2025 Financial Results on June 12, 2025
BEIJING, June 5, 2025 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital"), an AI-powered platform providing a comprehensive suite of financial and lifestyle services inAsia, announced that it plans to release its unaudited financial results for the first quarter endedMarch 31, 2025 b...
2025-06-05 17:30
4186
Hello Group Inc. Announces Unaudited Financial Results for the First Quarter of 2025
BEIJING, June 5, 2025 /PRNewswire/ -- Hello Group Inc. (NASDAQ: MOMO) ("Hello Group" or the "Company"), a leading player inAsia's online social and entertainment space, today announced its unaudited financial results for the first quarter of 2025. First Quarter of 2025 Highlights * Net reve...
2025-06-05 15:03
4448
Preliminary Data from Two Clinical Trials with ADC Candidates were Presented Orally at the 2025 ASCO Annual Meeting
SHANGHAI and CHICAGO, June 4, 2025 /PRNewswire/ -- The 2025 ASCO Annual Meeting is taking place inChicago, US, from May 30 to June 3. Duality Bio (HKEX: 9606.HK) presented the preliminary data of two clinical trials, HER3 ADC candidate DB-1310 and B7H3 ADC candidate DB-1311/BNT324, which is being...
2025-06-05 10:46
4204
Akeso's PD-1/CTLA-4 Bispecific Antibody Cadonilimab Approved for First-Line Treatment of Cervical Cancer in All-Comer Populations--Third Approved Indication for Cadonilimab
HONG KONG, June 4, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the National Medical Products Administration (NMPA) has approved the company's first- in-class PD-1/CTLA-4 bispecific antibody, cadonilimab, for the first-line treatment of persist...
2025-06-05 09:36
2124
Innovent's IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Receives Second NMPA Breakthrough Therapy Designation for Immuno-resistant Squamous Non-Small Cell Lung Cancer
SAN FRANCISCO and SUZHOU, China, June 4, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...
2025-06-05 08:23
2313
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Renal Cell Carcinoma
SAN FRANCISCO and SUZHOU, China, June 4, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...
2025-06-05 08:00
4258
Week's Top Stories
Most Reposted
AVPN's AI Opportunity Fund Expands Regional Efforts to Build AI Skilling Infrastructure for a Future-Ready Workforce Across Asia-Pacific
[Picked up by 302 media titles]
2026-01-21 12:39Government of Telangana and Blaize Sign MoU at Davos to Launch Telangana AI Innovation Hub and Advance Applied AI Initiatives
[Picked up by 297 media titles]
2026-01-22 15:16
Infobip strengthens leadership to drive growth and innovation
[Picked up by 282 media titles]
2026-01-16 11:00
Klook's study of 374,000 reviews finds that lesser-known cities create deeper emotional connection with travelers
[Picked up by 280 media titles]
2026-01-20 15:40
Novo Holdings Invests in Surya Hospitals to Strengthen Access to High-Quality Women's and Children's Healthcare in India
[Picked up by 277 media titles]
2026-01-20 09:00
